Floratek Pharma

Floratek Pharma is a UK-based biotechnology company focused on the discovery and development of novel small molecule therapeutics derived from plant sources. The company leverages a proprietary platform that integrates ethnobotanical knowledge with modern drug discovery techniques, including high-throughput screening and medicinal chemistry. Floratek's primary therapeutic focus is on oncology and inflammatory diseases, where it aims to identify and optimize bioactive compounds with unique mechanisms of action. The company's lead programs are currently in the pre-clinical stage, targeting solid tumors and chronic inflammatory conditions. By systematically exploring the chemical diversity of the plant kingdom, Floratek seeks to develop safer and more effective treatments for patients with high unmet medical needs.